NCT02611050

Brief Summary

This study is a multi-center randomized trial to evaluate the Multi-vessel Coronary Artery Disease Option Grid patient decision aid compared to usual care in patient reported decisional conflict, knowledge, and shared decision making.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable coronary-artery-disease

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

4 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2017

Completed
Last Updated

June 27, 2018

Status Verified

June 1, 2018

Enrollment Period

1.6 years

First QC Date

November 9, 2015

Last Update Submit

June 25, 2018

Conditions

Keywords

patient decision aidmulti-vessel coronary artery disease

Outcome Measures

Primary Outcomes (1)

  • Patient Decisional Conflict

    The Ottawa Decisional Conflict Scale is a validated measure of a patient's feeling of conflict with the decision making experience

    Collected immediately following patient's Option Grid or usual care clinical discussion, usually within 15 minutes after finishing the discussion.

Secondary Outcomes (5)

  • CollaboRATE Score

    Collected immediately following patient's Option Grid or usual care clinical discussion, usually within 15 minutes after finishing the discussion.

  • Treatment Knowledge

    Collected immediately following patient's Option Grid or usual care clinical discussion, usually within 15 minutes after finishing the discussion.

  • Patient Experience

    Within five days of the clinical discussion

  • Clinician Experience

    Within five days of the clinical discussion

  • Treatment Received

    Within 1 month of clinical discussion

Study Arms (2)

Option Grid

EXPERIMENTAL

Patients randomized to the Option Grid arm will receive the Multi-vessel Coronary Artery Disease Option Grid at the time of enrollment. The treating physician will then discuss the patient diagnosis and treatment choice reviewing the Option Grid within the conversation to facilitate patient understanding and shared decision making

Behavioral: The Multi-vessel Coronary Artery Disease Option Grid

Usual Care

OTHER

Patients randomized to usual care will discuss the patient diagnosis and treatment options typical to the physician's routine care.

Behavioral: Usual Care

Interventions

The Multi-vessel Coronary Artery Disease Option Grid is a patient decision aid used during the clinical visit. It is one page and contains a table a patient's frequently asked questions and the respective information for each treatment strategy. The Multi-vessel Coronary Artery Disease Option Grid was developed using patient and provider feedback and has been field-tested in clinic by cardiologists and surgeons.

Option Grid
Usual CareBEHAVIORAL

In usual care clinicians will discuss the patient diagnosis and treatment options typical to routine care for that clinician.

Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stable multi-vessel coronary artery disease diagnosed by coronary angiography defined as left main disease (\>50% stenosis) or multi-vessel coronary artery disease (\>70% stenosis in two or more coronary arteries)
  • At relative equipoise for at least two potential treatment options, in which the treating cardiologist or surgeon has determined the treatments are anatomically feasible and safe.

You may not qualify if:

  • Prior coronary artery bypass grafting
  • Unable to read or write English
  • Not cognitively able to participate in the Option Grid as determined by clinician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Maine Medical Center

Portland, Maine, 04102, United States

Location

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Location

Albany Medical Center

Albany, New York, 12208, United States

Location

Albany Stratton VA Medical Center

Albany, New York, 12208, United States

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Elizabeth L Nichols, MS

    The Dartmouth Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2015

First Posted

November 20, 2015

Study Start

September 20, 2015

Primary Completion

April 30, 2017

Study Completion

May 31, 2017

Last Updated

June 27, 2018

Record last verified: 2018-06

Locations